1. A questionnaire to collect unintended effects of transcranial magnetic stimulation: A consensus based approach. (September 2022) Authors: Giustiniani, A.; Vallesi, A.; Oliveri, M.; Tarantino, V.; Ambrosini, E.; Bortoletto, M.; Masina, F.; Busan, P.; Siebner, H.R.; Fadiga, L.; Koch, G.; Leocani, L.; Lefaucheur, J.P.; Rotenberg, A.; Zangen, A.; Violante, I.R.; Moliadze, V.; Gamboa, O.L.; Ugawa, Y.; Pascual-Leone, A. Journal: Clinical neurophysiology Issue: Volume 141(2022) Page Start: 101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy of topical imiquimod 3.75% in the treatment of actinic keratosis of the scalp in immunosuppressed patients: our case series. (2nd April 2020) Authors: Zavattaro, E.; Veronese, F.; Landucci, G.; Tarantino, V.; Savoia, P. Journal: Journal of dermatological treatment Issue: Volume 31:Number 3(2020) Page Start: 285 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. LONG TERM RESULTS OF THE FOLL05 RANDOMIZED STUDY COMPARING R‐CVP WITH R‐CHOP AND R‐FM AS FIRST LINE THERAPY IN PATIENTS WITH ADVANCED STAGE FOLLICULAR LYMPHOMA. A FIL STUDY. (June 2017) Authors: Luminari, S.; Tarantino, V.; Anastasia, A.; Boccomini, C.; Chiarenza, A.; Rigacci, L.; Angelucci, E.; Ferrari, A.; Pulsoni, A.; Rattotti, S.; Angrilli, F.; Gaidano, G.; Stelitano, C.; Bertoldero, G.; Cascavilla, N.; Salvi, F.; Ferreri, A.J.; Vallisa, D.; Balzarotti, M.; Cox, M.C. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. POD24 AND CR30 ARE PROMISING SURROGATE ENDPOINTS FOR ASSESSING THE OUTCOME OF PATIENTS WITH ADVANCED STAGE FOLLICULAR LYMPHOMA ENROLLED IN THE FOLL05 TRIAL BY FIL. (June 2017) Authors: Luminari, S.; Marcheselli, L.; Manni, M.; Anastasia, A.; Vitolo, U.; Chiarenza, A.; Rigacci, L.; Angelucci, E.; Fama, A.; Pulsoni, A.; Rattotti, S.; Angrilli, F.; Gaidano, G.; Stelitano, C.; Bertoldero, G.; Cascavilla, N.; Salvi, F.; Ferreri, A.J.; Tarantino, V.; Bellei, M. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 228 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PROGNOSTIC MODEL FOR HIGH TUMOR BURDEN FOLLICULAR LYMPHOMA INCLUDING BASELINE TOTAL METABOLIC TUMOR VOLUME AND END INDUCTION PET: a POOLED ANALYSIS FROM LYSA AND FIL TRIALS. (June 2017) Authors: Cottereau, A.; Versari, A.; Dupuis, J.; Chartier, L.; Menga, M.; Casasnovas, R.; Haioun, C.; Tilly, H.; Tarantino, V.; Dubreuil, J.; Federico, M.; Salles, G.; Luminari, S.; Trotman, J.; Meignan, M. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 116 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. THE RISK OF TRANSFORMATION OF FOLLICULAR LYMPHOMA "TRANSFORMED" BY RITUXIMAB: THE ARISTOTLE STUDY PROMOTED BY THE EUROPEAN LYMPHOMA INSTITUTE. (June 2017) Authors: Federico, M.; Caballero, D.; Marcheselli, L.; Tarantino, V.; Sarkozy, C.; Lopez Guillermo, A.; Wondergem, M.; Kimby, E.; Rusconi, C.; Zucca, E.; Montoto, S.; da Silva, M.G.; Aurer, I.; Paszkiewicz‐Kozik, E.; Cartron, G.; Morschhauser, F.; Alcoceba, M.; Chamuleau, M.; Lockmer, S.; Minoia, C. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗